Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter phase II study of ixazomib maintenance in patients with newly diagnosed mantle cell lymphoma
KCT0003034Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in mantle cell lymphoma (MCL), sponsored by Millennium Pharmaceuticals. Started Mar 2019; status: completed.
02
Drugs
ixazomib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on KCT0003034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003034.